ENDP Financial Facts
Selling, general and administrative: 159.9MBasic net income per share: -6.85
See Full Income Statement
Accounts payable: -553.45M
Accrued expenses: -2.17B
See Full Balance Sheet
Endo Pharmaceuticals Holdings Inc. (ENDP) Earnings
|
Expand Research on ENDP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +873.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/8/18 |  |
Q218 | $0.76 | $0.54 | +$0.22 | $715M | $678.35M |  |
 | | Details |
| 11/4/21 | |
Q321 | $0.80 | $0.46 | +$0.34 | $772M | $665.21M | = | | | Details |
8/8/16  |
|
Q216 | $0.86 | $0.74 | +$0.12 | $921M | $864.34M |  |
| | Details |
| 5/9/17 | |
Q117 | $1.23 | $1.10 | +$0.13 | $1.04B | $1.02B | = | | | Details |
| 11/9/17 | |
Q317 | $0.91 | $0.67 | +$0.24 | $787M | $784.56M | = | | | Details |
| 2/28/19 | |
Q418 | $0.75 | $0.59 | +$0.16 | $786M | $738.77M | = | | | Details |
| 5/6/21 | |
Q121 | $0.73 | $0.48 | +$0.25 | $718M | $668.65M | = | | | Details |
| 5/8/18 | |
Q118 | $0.67 | $0.55 | +$0.12 | $701M | $691.83M | |
| | Details |
